Skip to main content
. 2021 Aug;22(8):1139–1150. doi: 10.1016/S1470-2045(21)00288-6

Figure 3.

Figure 3

Subgroup analyses of the effect of trastuzumab

All analyses, except for site of first recurrence, include any loco-regional or distant recurrence but exclude contralateral disease. ER=oestrogen receptor. PR=progesterone receptor.